1. Home
  2. WVE vs BATRK Comparison

WVE vs BATRK Comparison

Compare WVE & BATRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$7.26

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Logo Atlanta Braves Holdings Inc. Series C

BATRK

Atlanta Braves Holdings Inc. Series C

HOLD

Current Price

$43.74

Market Cap

2.7B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
WVE
BATRK
Founded
2012
1991
Country
Singapore
United States
Employees
N/A
1610
Industry
Biotechnology: Pharmaceutical Preparations
Broadcasting
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.7B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
WVE
BATRK
Price
$7.26
$43.74
Analyst Decision
Strong Buy
Buy
Analyst Count
16
2
Target Price
$30.25
$57.00
AVG Volume (30 Days)
5.4M
272.3K
Earning Date
05-07-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,704,000.00
N/A
Revenue This Year
$0.34
$12.40
Revenue Next Year
$83.30
$8.54
P/E Ratio
N/A
N/A
Revenue Growth
149.43
N/A
52 Week Low
$5.02
$35.46
52 Week High
$21.73
$47.16

Technical Indicators

Market Signals
Indicator
WVE
BATRK
Relative Strength Index (RSI) 30.10 59.92
Support Level $6.94 $43.24
Resistance Level $8.29 $44.64
Average True Range (ATR) 0.75 0.97
MACD -0.50 -0.00
Stochastic Oscillator 26.85 91.17

Price Performance

Historical Comparison
WVE
BATRK

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About BATRK Atlanta Braves Holdings Inc. Series C

Atlanta Braves Holdings Inc is a holding company. It operates through its wholly-owned subsidiary, which is the owner and operator of the Atlanta Braves Major League Baseball Club and the mixed-use real estate development, The Battery Atlanta, and is the operator of the Atlanta Braves Major League Baseball Club's stadium, Truist Park. The company predominantly derives revenue related to the Braves baseball franchise and Truist Park from ticket sales, concessions, local broadcasting rights, advertising sponsorships, suites and premium seat fees, retail and licensing revenue, shared MLB revenue streams, including national broadcasting rights and licensing, and other sources. The company's reportable segments include: Baseball which generates key revenue, and Mixed-Use Development.

Share on Social Networks: